Drugs & Therapy Perspectives

Correction to: RBX2660 (REBYOTA^®) in preventing recurrence of Clostridioides difficile infection: a profile of its use in the USA

Pub Date : 2023-11-24 DOI: 10.1007/s40267-023-01035-8 Hannah A. Blair

Manage vitiligo with a personalised approach: consider old and new treatments

Pub Date : 2023-11-24 DOI: 10.1007/s40267-023-01032-x Nicole L. France

Ublituximab in relapsing forms of multiple sclerosis: a profile of its use

Pub Date : 2023-11-06 DOI: 10.1007/s40267-023-01030-z Hannah A. Blair